Industry Symposium by Guerbet
IND 15 - Elucirem™ (Gadopiclenol) - Clinical evidence of the innovative macrocyclic high-relaxivity low-gadolinium-dose GBCA
IND 15-1
15 min
The Paradigm Shift in Relaxivity and Stability with Elucirem
Jean-Sebastien Raynaud, Roissy CdG Cedex / France
Innovative Characteristics of the new macrocyclic high-relaxivity low-gadolinium-dose GBCA
IND 15-2
15 min
Elucirem Clinical Cases CNS
Laurie Loevner, Philadelphia / United States
IND 15-3
15 min
Elucirem Clinical Cases Body
B. Nicolas Bloch, Boston / United States
IND 15-4
10 min
Q&A
Jean-Sebastien Raynaud, Roissy CdG Cedex / France
Lectures
1
The Paradigm Shift in Relaxivity and Stability with Elucirem
15:00Jean-Sebastien Raynaud, Roissy CdG Cedex / FR
2
Elucirem Clinical Cases CNS
15:00Laurie Loevner, Philadelphia / US
3
Elucirem Clinical Cases Body
15:00B. Nicolas Bloch, Boston / US
4
Q&A
10:00Jean-Sebastien Raynaud, Roissy CdG Cedex / FR